Skip to main content

 News

COVID-19 : Visits not permitted from Saturday 17/10/2020

16/10/2020 Coronavirus COVID-19 :
Visitors are no longer permitted at the Jules Bordet Institute from Saturday 17/10/2020 To protect patients and members of staff following the increase in the number of persons testing positive for Covid-19, visits to patients hospitalised at the Jules Bordet Institute are no longer permitted from Saturday 17 October 2020, except in special cases (in which case you should contact the care personnel…
(read more)

OncLive® inducts the Giants of Cancer Care® 2020

Press release (09/10/2020)  OncLive® inducts the Giants of Cancer Care® 2020 : The award in the Breast Cancer category goes to Professor Martine Piccart, Director of Scientific Research at the Jules Bordet Institute 09/10/2020 - OncLive®, the international multimedia information platform dedicated to oncology, has announced the eighth annual Giants of Cancer Care® class of inductees. Every year this recognition programme honours 15 leaders of…
(read more)

Prof. Martine Piccart gives an update on breast cancer research

Press release (05/10/2020)  Breast cancer research is progressing and enabling breast clinics to propose a tailor-made treatment for many cancers Brussels, 5 October 2020 – Professor Martine Piccart, Director of Scientific Research at the Jules Bordet Institute, details the very real progress that is enabling breast clinics to propose an increasingly personalised treatment plan, coupled with a significant de-escalation of treatment for…
(read more)

2020 Scientific Report - Jules Bordet Institute

Thursday 10/09/2020 Jules Bordet Institute – 2020 Scientific Report Leading-edge research and ambitious projects in the service of the fight against cancer  Translational research and clinical research are part of the Jules Bordet Institute's ADN as it seeks to rapidly bring research discoveries to the patient's bedside. This 2016-2019 scientific report reflects the spirit of commitment and collaboration of the Institute's health…
(read more)

Manneken-Pis pays tribute to hospitals staff

Monday 7/09/2020 Manneken-Pis pays tribute to hospitals staff The City of Brussels, in collaboration with "Les Héros d'Iris", offered a new costume to Manneken-Pis on Saturday 5 September. The famous ketje donned a costume representing the various hospital professions: nurses, cleaners, nursing assistants, doctors, administrative staff, technicians and all the people who support the activities of a hospital. With this gesture, the City intends…
(read more)

The MyPeBS clinical study: for a new breast cancer screening strategy?

The MyPeBS clinical study: for a new breast cancer screening strategy?  The aim of MyPeBS  (MyPersonalBreast Cancer Screening) is to evaluate a breast cancer screening strategy based on individual risk.    A total of 26 international partners are participating in MyPeBS. The clinical study is taking place in five countries (Belgium, France, Italy, the United Kingdom, Israel) and is coordinated by  Unicancer (France). In Belgium it is being…
(read more)

National health plan for cancer patients!

Press release (10/04/2020) A national health plan for cancer patients to avoid a wave of collateral victims! Brussels, 10 April 2020 – The crisis linked to the Covid-19 virus is currently responsible for a slowdown across the range of care needed in the treatment of cancer. As cancer is a major cause of mortality in Belgium the consequences of this must not be under-estimated. The Jules Bordet Institute, the Belgian reference centre for…
(read more)

Coronavirus COVID-19 – Appeal for donations

27/03/2020  Coronavirus COVID-19 – Appeal for donations For several weeks now our teams have been working non-stop to prepare optimal care for our patients in the context of the coronavirus epidemic. The care staff are training and the care units are equipped themselves and reorganising.    Would you like to support the Jules Bordet Institute during this pandemic?   “The Friends of the Bordet Institute”, the Institute’s principal private…
(read more)